Antonio Cavaliere

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

Cosimo Durante, Efisio Puxeddu, Elisabetta Ferretti et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 389 citations · Full text

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Brunangelo Falini, Leonardo Flenghi, Stefano Pileri et al. · PubMed · 1993 · 301 citations

BRAF^V599EMutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas

Efisio Puxeddu, Sonia Moretti, Rossella Elisei et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 262 citations

Braf Mutation, Braf Gene, Medicine +14

Correlation between B-RAFV600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature

Laura Fugazzola, Efisio Puxeddu, Nicola Avenia et al. · Endocrine Related Cancer · 2006 · 235 citations · Full text

Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer

Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola et al. · Journal of Thoracic Oncology · 2011 · 176 citations · Full text

Kras Mutations, Medicine, Receptor Tyrosine Kinase +8